Chronic ingestion of uranium in drinking water: A study of kidney bioeffects in humans

Toxicological Sciences

Volumn 43, Issue 1, 1998, Pages 68-77

  Limson Zamora, M ^a   Tracy, B L ^a   Zielinski, J M ^a   Meyerhof, D P ^a   Moss, M A ^b  

^a HEALTH CANADA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA 2 MICROGLOBULIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; PROTEIN; URANIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; FEMALE; GLOMERULUS; HUMAN; INGESTION; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; URINARY EXCRETION; WATER CONTAMINATION;

GLOMERULUS;

EID: 15444344417     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1006/toxs.1998.2426     Document Type: Article

References (48)

1. Albert, A., Orlowski, M., and Szewczuk, A. (1961). Histochemical demonstration of gamma-glutamyl transpeptidase. Nature 191, 767-768.
2. Bassett, W. H. (1948). The excretion of hexavalent uranium following intravenous administration. In Studies on Human Subjects UR-37. University of Rochester Atomic Energy Project, New York.
3. Benscome, S. A., Stone, R. S., Latta, H., and Madden, S. C. (1960). Acute tubular and glomerular lesions in rat kidneys after uranium injury. Arch. Pathol. 69, 122-128.
4. Blantz, R. C., Pelayo, J. C., Gushwa, L. C., Myers, R., and Evan, A. P. (1985). Functional basis for the glomerular alterations in uranyl nitrate acute renal failure. Kidney Int. 228, 733-743.
5. Bonting, S. L., Pollack, V. E., Muehrke, R. C., and Kark, R. (1960). Quantitative histochemistry of the nephron. III. Lactic dehydrogenase activity in man and other species. J. Clin. Invest. 39, 1381-1385.
6. Bourbouze, R., Baumann, F. C., Bonvalet, J. P., and Farman, N. (1984). Distribution of N-acetyl-β-D-glucosaminiadse along the rabbit nephron. Kidney Int. 25, 636-642.
7. Burtis, C. A., and Ashwood, E. R. (Eds.) (1994). Reference intervals. In Tietz Textbook of Clinical Chemistry, pp. 2175-2211. Saunders, Philadelphia.
8. Butterworth, P. J., Moss, E. W., Pitkanen, E., and Pringle, A. (1965). Patterns of urinary excretion of alkaline phosphatase in acute renal failure. Clin. Chim. Acta. 11, 212-219.
9. ++ metabolism in kidney mitochondria during acute uranium intoxication. Lab. Invest. 25, 516-527.
10. Clarkson, T. W., and Kench, J. E. (1956). Urinary excretion of amino acids by men absorbing heavy metals. Biochem. J. 62, 361-372.
11. Davison, A. M., Cumming, A. D., and Swainson, C. P. (1995). Diseases of the kidney and urinary tract. In Davidson's Principles and Practice of Medicine (C. R. W. Edwards, I. A. D. Bouchier, and C. Haslett, Eds.), pp. 611-668. Churchill Livingstone, Edinburgh.
12. Diamond, G. L., Morrow, P. E., Panner, B. J., Gelein, R. M., and Batt, R. B. (1989). Reversible uranyl fluoride nephrotoxicity in the Long Evans rat. Fundam. Appl. Toxicol. 13, 65-78.
13. Galle, P. (1974). Role des lysosomes et des mitochondries dans les phenomenes de concentration et d'elemination d'elements mineraux (uranium et or) par le rein. J. Microscopie 19, 17-24.
14. Gilman, A. P., Villeneuve, D. C., Secours, V. E., Yagminas, A. P., Tracy, B. L., Quinn, J. M., Valli, V. E., Wiles, R. J., and Moss, M. A. (1998a). Uranyl nitrate: 28-day and 91-day toxicity studies in the Sprague-Dawley rat. Toxicol. Sci, 41, 117-128.
15. Gilman, A. P., Villeneuve, D. C., Secours, V. E., Yagminas, A. P., Tracy, B. L., Quinn, J. M., Valli, V. E., and Moss, M. A. (1998b). Uranyl nitrate: 91-day toxicity studies in the New Zealand white rabbit. Toxicol. Sci. 41, 129-137.
16. Gilman, A. P., Villeneuve, D. C., Secours, V. E., Yagminas, A. P., Tracy, B. L., Quinn, J. M., Valli, V. E., and Moss, M. A. (1998c). Uranyl nitrate: 91-day exposure and recovery studies in the New Zealand white rabbit. Toxicol. Sci. 41, 138-151.
17. Haley, D. P., Bulger, R. E., and Dobyan, D. C. (1982). The long-term effects of uranyl nitrate on the structure and function of the rat kidney. Virchows Arch. B 41, 181-192.
18. Health and Welfare Canada (1996). Guidelines for Canadian Drinking Water Quality, 6th ed., H48-10/1996E. Canada Communications Group Publishing, Ottawa.
19. Health and Welfare Canada (1979-1988). Environmental Radioactivity in Canada (Radiological Monitoring Annual Reports). Radiation Protection Bureau, Ottawa.
20. Hursh, J. B., Neuman, W. R., Toribara, T., Wilson, H., and Waterhouse, C. (1969). Oral ingestion of uranium by man. Health Phys. 17, 619-621.
21. Jung, K., Kirschner, P., Wille, A., and Brien, G. (1993). Excretion of urinary enzymes after extracorporeal shockwave lithotripsy: A critical revaluation. J. Urol 149, 1409-1413.
22. Kirschbaum, B. B. (1982). Aggregation of renal brush border membranes by concanavalin A and heavy metals. Toxicol. Appl. Pharmacol. 64, 10-19.
23. Laszlo, S., and Szabo, A. (1982). Gamma-glutamyl transpeptidase activity in human urine. Clin. Chim. Acta 126, 9-16.
24. Leggett, R. W. (1989). The behavior and chemical toxicity of U in the kidney: A reassessment. Health Phys. 57, 365-383.
25. Lehman, E. L. (1975). Nonparametrics: Statistical Methods Based on Ranks. Holden-Day, San Francisco.
26. Lentner, C. (Ed.) (1981). Units of measurement, body fluids, composition of the body, nutrition. In Geigy Scientific Tables, Vol. 1, pp. 81-83. Ciba-Geigy Ltd., Basle.
27. Lillehoj, E. P., and Poulik, M. D. (1986). Normal and abnormal aspects of proteinuria. I. Mechanisms, characteristics and analyses of urinary protein. II. Clinical considerations. Exp. Pathol. 29(1), 1-28.
28. Luessenhop, A. J., Gallimore, J. C., Sweet, W. H., Struxness, G., and Robinson, J. (1958). The toxicity in man of hexavalent uranium following intravenous administration. Am. J. Roentgenol. Radium Ther. Nucl. Med. 79, 83-100.
29. Mao, Y., Desmeules, M., Schaubel, D., Berube, D., Dyck, R., Brule, D., and Thomas, B. (1995). Inorganic components of drinking water and microalbuminuria. Environ. Res. 71, 135-140.
30. Meyer, R. J., and Pietsch, E. (1936). Gmelins Handbuch der anorganischen Chemie, 8th ed., System No. 55. Verlag Chemie g.m.b.h., Leipzig/Berlin.
31. Mogensen, C. E., Damsgaard, E. M., Froland, A., Nielsen, S., de Fine, Olivarious, N., and Schmilz, A. (1992). Microalbuminuria in non-insulin-dependent diabetes. Clin. Nephrol. 38(Suppl. 1), S28-39.
32. Moss, M. A., McCurdy, R. F., Dooley, K. C., Givener, M. L., Dymond, L. C., Slater, J. M., and Courneya, M. M. (1983). Uranium in drinking water -Report on clinical studies in Nova Scotia. In Chemical Toxicology and Clinical Chemistry of Metals (S. S. Brown, and J. Savory, Eds.), pp. 149-152. Academic Press. London.
33. Nechay, B. R., Thompson, J. D., and Saunders, J. P. (1980). Inhibition by uranyl nitrate of adenosine triphosphatases derived from animal and human tissues. Toxicol. Appl. Pharmacol. 53, 410-419.
34. Niwa, T., Katzuzaki, T., Yazawa, T., Tatemichi, H., Emoto, Y., Miyazaki, T., and Maeda, K. (1993). Urinary trehalase activity in chronic glomerulonephritis. Nephron 63(4), 423-442.
35. Nomiyama, K., Yamamoto, A., and Sato, C. (1974). Assay of urinary enzymes in toxic nephropathy. Toxicol. Appl. Pharmacol. 27, 484-490.
36. Nomiyama, K., and Foulkes, E. C. (1968). Some effects of uranyl acetate on proximal tubular function in rabbit kidney. Toxicol. Appl. Pharmacol. 13, 89-98.
37. Price, R. G. (1982). Urinary enzymes, nephrotoxicity and renal disease. Toxicology (Ireland), 23 (2-3), 99-134.
38. 2-induced alterations in ion transport. Kidney Int. 10, 123-127.
39. Shapiro, S. S., and Wilk, M. B. (1965). An analysis of variance test for normality (complete samples). Biometrika 52, 591-611.
40. Stannard, J. N. (1988). Uranium. In Radioactivity and Health: A History (R. W. Balmaan, Jr., Ed.), pp. 79-111. Office of Scientific and Technical Information, Springfield, VA.
41. Stroo, W. E., and Hook, J. B. (1977). Enzymes of renal origin in urine as indicators of nephrotoxicity. Toxicol. Appl. Pharmacol. 39, 423-434.
42. Struxness, E. G., Luessenhop, A. J., Bernard, S. R., and Gallimore, J. C. (1955). The distribution and excretion of hexavalent uranium in man. In Proceedings of the International Conference on the Peaceful Uses of Atomic Energy, Vol. 10, pp. 186-196. United Nations, New York.
43. Terepka, A. R., Toribara, T. Y., and Neuman, W. F. (1965). Skeletal Retention of Uranium in Man. Presented at the 46th Meeting of the Endocrine Society, San Francisco.
44. Thun, M. J., Baker, D. B., Steenland, K., Smith, A. B., Halperin, W., and Berl, T. (1985). Renal toxicity in uranium mill workers. Scand. J. Work. Environ. Health 11, 83-90.
45. Voegtlin, C., and Hodge, H. C. (Eds.) (1949). Pharmacology and Toxicology of Uranium Compounds, National Nuclear Energy Series, Division VI, Volume I, Parts I and II. McGraw-Hill, New York.
46. World Health Organization (WHO) (1991). Principles and Methods for the Assessment of Nephrotoxicity Associated with Exposure to Chemicals, Environmental Health Criteria 119, Geneva.
47. Yuile, C. L. (1973). Animal experiments. In Uranium, Plutonium, Transplutonic Elements (H. C. Hodge, J. N. Stannard, and J. B. Hursh, Eds.), Vol. 36, pp. 165-196.
48. Zalups, R., Gelein, R., Morrow, P., and Diamond, G. (1988). Nephrotoxicity of uranyl fluoride in uni-nephrectomized and sham-operated rat. Toxicol. Appl. Pharmacol. 94, 11-22.